Alkylating Drug drugs compared

Compare all 19 Alkylating Drug drugs side by side, used for conditions such as leukemia, lymphoid, lymphoma, non-hodgkin, brain neoplasms. They share one FDA-defined mechanism but differ in approved uses, prescription status, brand-vs-generic options, price, and FDA recall-safety record — which our independent rating scores. The highest-rated is bendeka.

Top-rated alkylating drug: 1. Bendeka · 2. Gleostine · 3. Gliadel

Alkylating Drug drugs compared side by side, with pharmaranks' FDA recall-safety rating
Drug	Generic	Form	Status	Used for	Safety ratingFDA recall-based	Pharmacy pays
Bendeka	Bendamustine Hydrochloride	Injectable	Prescription	Leukemia, Lymphoid, Lymphoma, Non-Hodgkin	70/100	—
Gleostine	Lomustine	Capsule	Prescription	Brain Neoplasms, Colonic Neoplasms	70/100	—
Gliadel	Carmustine	Wafer	Prescription	Brain Neoplasms, Carcinoma	70/100	—
Vivimusta	Bendamustine Hydrochloride	Injectable	Prescription	Leukemia, Lymphoid, Lymphoma, Non-Hodgkin	70/100	—
Evdi	Trabectedin	Injectable	Prescription	Leiomyosarcoma, Liposarcoma	66/100	—
Ivra	Melphalan Hydrochloride	Injectable	Prescription	Breast Neoplasms, Multiple Myeloma	66/100	—
Bicnu	Carmustine	Kit	Prescription	Brain Neoplasms, Carcinoma	Not yet rated	—
Busulfex	Busulfan	Injectable	Prescription	Polycythemia Vera, Leukemia, Myelogenous, Chronic, Bcr-Abl Positive	Not yet rated	—
Evomela	Melphalan Hydrochloride	Injectable	Prescription	Breast Neoplasms, Multiple Myeloma	Not yet rated	—
Hepzato	Melphalan Hydrochloride	Kit	Prescription	Breast Neoplasms, Multiple Myeloma	Not yet rated	—
Lomustine	—	Capsule	Prescription	Brain Neoplasms, Colonic Neoplasms	Not yet rated	—
Melphalan Hydrochloride	—	Kit	Prescription	Breast Neoplasms, Multiple Myeloma	Not yet rated	—

The safety rating column is unique to pharmaranks — an independent 0–100 score from FDA regulatory recall data. Higher is safer. Not medical advice.

Best alkylating drug by condition

for lymphoid leukemia for non-hodgkin lymphoma for brain neoplasms for colonic neoplasms for hodgkin disease for kidney neoplasms

Full ranking · 19 drugs

Frequently asked questions

What is the Alkylating Drug drug class?

Alkylating Drug is an FDA Established Pharmacologic Class (EPC) — a group of drugs that share a mechanism of action. pharmaranks lists 19 Alkylating Drug products, each independently rated.

Are all Alkylating Drug drugs the same?

No. Alkylating Drug drugs share the same core mechanism — that is why they sit in one FDA class — but they differ in their approved uses, available forms, whether they are prescription or over-the-counter, brand-vs-generic options and price, and their FDA recall-safety record.

What conditions do Alkylating Drug drugs treat?

Per NIH RxClass drug-classification data, Alkylating Drug drugs are used for conditions including leukemia, lymphoid, lymphoma, non-hodgkin, brain neoplasms, colonic neoplasms, hodgkin disease, kidney neoplasms.

Which Alkylating Drug drug is best-rated?

By our independent rating, bendeka currently ranks highest among Alkylating Drug drugs. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.

Sources: the Alkylating Drug class definition and its member drugs come from the U.S. NLM RxClass (Established Pharmacologic Class); how the class works is summarized from Cyclophosphamide — StatPearls, NCBI Bookshelf (NIH). Ratings are pharmaranks’ independent FDA recall-safety analysis.